Showing results (1691-1700 of 2,033) with videos related to
Sort By:
Pageof 204
Journal of Medicinal Chemistry|June 17, 2021
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A<sub>4</sub> Mimetics (QNX-sLXms)Monica de Gaetano, Catherine Tighe, Kevin Gahan, et al.Diabetes Research and Clinical Practice|September 25, 2023
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitusIshant Khurana, Natasha J Howard, Scott Maxwell, et al.The Journal of Biological Chemistry|November 21, 1998
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failureK P Moore, S G Holt, R P Patel, et al.Redox Biology|March 24, 2025
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetesInez A Trambas, Lilliana Bowen, Vicki Thallas-Bonke, et al.Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2015
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular RemodelingStephen P Gray, Elyse Di Marco, Kit Kennedy, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.Diabetes Care|March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ONMuh Geot Wong, Vlado Perkovic, John Chalmers, et al.Journal of Dental Research|May 24, 2017
Dental Decay Phenotype in Nonsyndromic Orofacial CleftingB J Howe, M E Cooper, G L Wehby, et al.Clinical Science (London, England : 1979)|August 28, 2012
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetesMona Sedeek, Alex Gutsol, Augusto C Montezano, et al.Pageof 204